Dexcel Pharma Technologies Ltd.

Overview

• HeadquartersL3¹

See how the biggest companies compare on our leaderboards

Corporate structure

Dexcel Pharma Technologies Ltd. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Stakes it holds

Dexcel Pharma Technologies Ltd. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• RoivantSC 13G/A Feb 10, 2022 to Feb 14, 2024²